Merit Medical Systems Inc (MMSI)
73.74
+0.36
(+0.49%)
USD |
NASDAQ |
Apr 26, 16:00
73.74
0.00 (0.00%)
After-Hours: 20:00
Merit Medical Systems Revenue (Quarterly): 324.52M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 324.52M |
| September 30, 2023 | 315.23M |
| June 30, 2023 | 320.06M |
| March 31, 2023 | 297.56M |
| December 31, 2022 | 293.42M |
| September 30, 2022 | 287.18M |
| June 30, 2022 | 294.98M |
| March 31, 2022 | 275.42M |
| December 31, 2021 | 278.49M |
| September 30, 2021 | 267.02M |
| June 30, 2021 | 280.32M |
| March 31, 2021 | 248.91M |
| December 31, 2020 | 258.00M |
| September 30, 2020 | 243.98M |
| June 30, 2020 | 218.37M |
| March 31, 2020 | 243.52M |
| December 31, 2019 | 257.92M |
| September 30, 2019 | 243.05M |
| June 30, 2019 | 255.53M |
| March 31, 2019 | 238.35M |
| December 31, 2018 | 233.25M |
| September 30, 2018 | 221.66M |
| June 30, 2018 | 224.81M |
| March 31, 2018 | 203.04M |
| December 31, 2017 | 190.90M |
| Date | Value |
|---|---|
| September 30, 2017 | 179.34M |
| June 30, 2017 | 186.55M |
| March 31, 2017 | 171.07M |
| December 31, 2016 | 157.72M |
| September 30, 2016 | 156.98M |
| June 30, 2016 | 151.07M |
| March 31, 2016 | 138.08M |
| December 31, 2015 | 138.40M |
| September 30, 2015 | 136.09M |
| June 30, 2015 | 138.08M |
| March 31, 2015 | 129.58M |
| December 31, 2014 | 132.78M |
| September 30, 2014 | 128.81M |
| June 30, 2014 | 128.86M |
| March 31, 2014 | 119.24M |
| December 31, 2013 | 120.02M |
| September 30, 2013 | 115.21M |
| June 30, 2013 | 109.88M |
| March 31, 2013 | 103.95M |
| December 31, 2012 | 102.23M |
| September 30, 2012 | 95.91M |
| June 30, 2012 | 100.53M |
| March 31, 2012 | 95.62M |
| December 31, 2011 | 91.09M |
| September 30, 2011 | 90.48M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
218.37M
Minimum
Jun 2020
324.52M
Maximum
Dec 2023
273.87M
Average
275.42M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Becton Dickinson & Co | 4.706B |
| Integer Holdings Corp | 413.15M |
| Abbott Laboratories | 9.964B |
| Insulet Corp | 509.80M |
| West Pharmaceutical Services Inc | 732.00M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.63M |
| Total Expenses (Quarterly) | 291.38M |
| EPS Diluted (Quarterly) | 0.48 |
| Enterprise Value | 4.487B |
| Gross Profit Margin (Quarterly) | 46.39% |
| Profit Margin (Quarterly) | 8.51% |
| Earnings Yield | 2.21% |
| Operating Earnings Yield | 2.93% |
| Normalized Earnings Yield | 2.248 |